Our commitment to greater equality in genomic healthcare
We are committed to greater equality in genomic healthcare for the communities we serve, ensuring that everyone has access to the healthcare they need while treating people with respect, dignity, and fairness, where:
- Diversity is valued and respected – an approach that embraces both visible and non-visible difference
- We all work together effectively in an atmosphere of trust, harmony, and respect
- Discrimination and prejudice are challenged
- Both direct and indirect discrimination (including associative and perceptive discrimination)
We will ensure there is equal access to the nationally commissioned genomic tests as set out in the National Genomics Test Directory, regardless of where the patient lives or how and where they access healthcare.
Our Equality, Diversity and Inclusion (EDI) Strategy 2022-2024 reflected our ongoing commitment to the development and embedding of genomic services in routine healthcare, which meets the needs of our diverse population and continuously improve the way we interact with our stakeholders.
Achieving health equity in the application of genomic medicine requires greater access and availability of genomic information from the diverse population of the North West.
To read the full article please our news and articles page.
Genomics, health inequalities, and an integrated approach in the provision of precision medicine
The scripts for the production are available to download, and translate via Google Translate.